XML 25 R14.htm IDEA: XBRL DOCUMENT v3.25.1

Balance Sheet Components

3 Months Ended

Mar. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Balance Sheet Components

BALANCE SHEET COMPONENTS

Inventory

Inventory consisted of the following (in thousands):

			March 31, 2025						December 31, 2024
Finished goods			$	4,420					$	4,819
Work in progress			4,806						3,793
Raw materials			13,703						10,891
Total inventory			$	22,929					$	19,503

Accrued and Other Liabilities

Accrued and other liabilities consisted of the following (in thousands):

			March 31, 2025						December 31, 2024
Clinical studies			$	16,703					$	16,166
Short-term lease liability			6,205						6,103
Professional fees			6,199						5,971
Deferred revenue			5,422						4,848
Laboratory processing fees and materials			3,101						3,184
Travel and expenses			1,237						819
Contingent consideration			960						2,414
Accrued shipping expenses			462						504
Accrued royalty			262						255
Deferred payments for intangible assets			250						250
License and other collaboration fees			—						67
Capital expenditures			—						126
Other accrued expenses			2,094						2,645
Total accrued and other liabilities			$	42,895					$	43,352

X

- References

No definition available.

+ Details

Name:	us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/210/tableOfContent

+ Details

Name:	us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration